• Mubritinib (TAK 165): OXPHOS Targeting and AML Vulnerability

  2026-08-05

  Explore how Mubritinib (TAK 165) redefines targeted cancer research by selectively inhibiting mitochondrial OXPHOS in chemotherapy-resistant AML. This article uniquely unpacks assay design, mechanistic depth, and translational impact beyond classic HER2 signaling.

• Rhodamine 123 (chloride): Illuminating ABC Transporter Dynam

  2026-08-05

  Explore how Rhodamine 123 (chloride) reveals real-time ABC transporter function in multidrug resistance research. This in-depth guide highlights advanced mechanistic insights and practical assay implications, distinguishing it from standard protocol articles.

• Hoechst 33342: Applied Protocols for Nuclear Imaging & Cell

  2026-08-04

  Hoechst 33342, a bis-benzimidazole fluorescent dye, powers advanced nuclear imaging workflows for live-cell analysis, apoptosis, and cell cycle studies. This article details hands-on protocols, troubleshooting tips, and insights linking mitochondrial metabolism and chromatin visualization—bridging cutting-edge findings to practical bench use.

• APEX2 Is Essential for TERT Expression in Human Stem Cells

  2026-08-04

  This study uncovers a specific requirement for the DNA repair enzyme APEX2 in facilitating efficient TERT gene expression in human embryonic stem cells and melanoma cells. By dissecting the molecular relationship between APEX2, repetitive genomic elements, and telomerase regulation, the work advances our understanding of stem cell maintenance and identifies new pathways influencing cancer and aging.

• Erastin and the Translational Frontier of Ferroptosis Resear

  2026-08-03

  Explore how Erastin, a potent ferroptosis inducer, is redefining cancer biology research and translational strategy. This article blends mechanistic insight with actionable guidance for researchers, leveraging recent breakthroughs in oxidative stress and RAS-driven tumor models, and situates Erastin’s role at the cutting edge of precision oncology.

• Viral Inducers of RIPK3 Degradation: Mechanisms Regulating N

  2026-08-03

  Liu et al. identify a class of orthopoxvirus-encoded proteins that target the necroptosis adaptor RIPK3 for proteasomal degradation, suppressing inflammatory cell death and modulating virus-induced inflammation. This work reveals an evolutionary strategy by which viruses evade necroptosis to optimize replication and pathogenesis, with broad implications for cell death research.

• Cyanidin Chloride Modulates Inflammation and Barrier in Psor

  2026-08-02

  This study demonstrates that cyanin chloride, a glycosylated form of cyanidin, exerts potent anti-inflammatory and skin barrier-restorative effects in a TNF-α/IL-17A/IFN-γ-induced HaCaT psoriasis cell model. The findings highlight its dual action on cytokine suppression and enhancement of epidermal integrity, supporting its value as a natural candidate for advanced oxidative stress and inflammatory skin research.

• 1,2-Dioleoyl-3-trimethylammonium-propane Chloride: Advanced

  2026-08-01

  Explore the unique capabilities of 1,2-Dioleoyl-3-trimethylammonium-propane chloride (DOTAP) in functional genomics and localized ocular gene delivery. This comprehensive article reveals how DOTAP's distinct properties accelerate lipid nanoparticle optimization and transform targeted therapies beyond conventional gene transfection reagents.

• Biotin-XX Tyramide: Redefining Cell Surface Proteomics

  2026-07-31

  This article explores how Biotin-XX Tyramide Reagent (biotin-LC-LC-tyramide) enables ultra-selective, membrane-impermeant cell surface protein profiling and signal amplification. By integrating mechanistic insights, recent protocol advances, and translational strategy, we chart a roadmap for next-generation spatial proteomics in neuroscience and beyond.

• Erastin: Precision Ferroptosis Inducer for Cancer Biology Re

  2026-07-31

  Erastin, a small molecule ferroptosis inducer from APExBIO, offers cancer researchers a robust tool to dissect iron-dependent non-apoptotic cell death—specifically in RAS/BRAF-mutant models. This article details optimized workflows, troubleshooting strategies, and protocol parameters for leveraging Erastin in oxidative stress assays and tumor cell vulnerability studies.

• Polygodial Enables Precision TRPA1 Modulation in Sensory Bio

  2026-07-30

  TRPA1 channel activation is central to understanding neurogenic inflammation, yet translational research has long lacked reliable, mechanism-based tools for dissecting this pathway. This article explores how Polygodial, a crystalline small molecule and validated TRPA1 channel activator, empowers researchers to mechanistically interrogate sensory neuron and epithelial signaling—bridging new mechanistic insight with practical guidance for advanced neurophysiology and membrane transporter studies. Drawing on recent discoveries about TRPV1 and TRPA1 roles in airway inflammation, we highlight the unique advantages of Polygodial and provide actionable protocol parameters, strategic context, and a forward-looking outlook for translational teams.

• WP1066, JAK2/STAT3 Inhibitor: Mechanisms & Research Utility

  2026-07-30

  WP1066 is a potent, cell-permeable JAK2/STAT3 inhibitor with proven antiproliferative and pro-apoptotic effects in cancer and regenerative models. Its mode of action involves inhibition of JAK2 phosphorylation, leading to downstream suppression of STAT3 and STAT5 signaling. WP1066’s efficacy in both xenograft and in vitro assays positions it as a critical tool for oncology and bone repair research.

• SAR131675: Redefining VEGFR-3 Inhibition in Lymphangiogenesi

  2026-07-29

  Explore how SAR131675, a selective VEGFR-3 inhibitor, enables unprecedented mechanistic clarity in lymphangiogenesis research. This article delivers a nuanced scientific analysis, bridging molecular selectivity with practical assay design and translational limitations.

• CP-673451: Selective PDGFRα/β Inhibitor for Advanced Cancer

  2026-07-29

  CP-673451 enables precise, nanomolar-level inhibition of PDGFRα and PDGFRβ, unlocking new frontiers in angiogenesis and tumor suppression studies. Its proven selectivity and robust in vivo efficacy make it a cornerstone for dissecting PDGFR-driven pathways, especially in challenging models like ATRX-deficient glioblastoma.

• Bazedoxifene: Dual-Pathway Modulation for Osteoporosis and C

  2026-07-28

  Explore how Bazedoxifene, a third-generation selective estrogen receptor modulator, advances osteoporosis treatment research and uniquely inhibits IL-6/GP130 signaling in cancer studies. This article reveals mechanistic insights and application strategies for researchers.

408 records 6/28 page Previous Next First page 上5页 678910 下5页 Last page